Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-21-037981

President and CEO sold 18,333 shares at an average $61.40 ($1,125,648)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Watts Ryan J. President and CEO 2021-06-01 Sale −13,127 $60.98 $800,511 2,215,948 I
Watts Ryan J. President and CEO 2021-06-01 Sale −2,750 $62.09 $170,748 2,213,198 I
Watts Ryan J. President and CEO 2021-06-01 Sale −2,102 $62.76 $131,911 2,211,096 I
Watts Ryan J. President and CEO 2021-06-01 Sale −354 $63.50 $22,479 2,210,742 I
Open-market sales · 18,333 sh · avg $61.40 · $1,125,648
Loading xslF345X03/doc4.xml…